Back to Browse Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 8

Deficiency of α-1-antitrypsin influences systemic iron homeostasis

Authors Ghio AJ, Soukup JM, Richards JH, Fischer BM, Voynow JA, Schmechel DE

Published Date January 2013 Volume 2013:8 Pages 45—51

DOI http://dx.doi.org/10.2147/COPD.S37897

Received 8 September 2012, Accepted 28 October 2012, Published 22 January 2013

Andrew J Ghio,1 Joleen M Soukup,1 Judy H Richards,1 Bernard M Fischer,2 Judith A Voynow,2 Donald E Schmechel3

1US Environmental Protection Agency, Chapel Hill, NC, USA; 2Division of Pediatric Pulmonary Medicine, Department of Pediatrics,3Joseph and Kathleen Bryan Alzheimer Disease Research Center, Department of Medicine (Neurology), Duke University Medical Center, Durham, NC, USA

Abstract: There is evidence that proteases and antiproteases participate in the iron homeostasis of cells and living systems. We tested the postulate that α-1 antitrypsin (A1AT) polymorphism and the consequent deficiency of this antiprotease in humans are associated with a systemic disruption in iron homeostasis. Archived plasma samples from Alpha-1 Foundation (30 MM, 30 MZ, and 30 ZZ individuals) were analyzed for A1AT, ferritin, transferrin, and C-reactive protein (CRP). Plasma samples were also assayed for metals using inductively coupled plasma atomic emission spectroscopy (ICPAES). Plasma levels of A1AT in MZ and ZZ individuals were approximately 60% and 20% of those for MM individuals respectively. Plasma ferritin concentrations in those with the ZZ genotype were greater relative to those individuals with either MM or MZ genotype. Plasma transferrin for MM, MZ, and ZZ genotypes showed no significant differences. Linear regression analysis revealed a significant (negative) relationship between plasma concentrations of A1AT and ferritin while that between A1AT and transferrin levels was not significant. Plasma CRP concentrations were not significantly different between MM, MZ, and ZZ individuals. ICPAES measurement of metals confirmed elevated plasma concentrations of nonheme iron among ZZ individuals. Nonheme iron concentrations correlated (negatively) with levels of A1AT. A1AT deficiency is associated with evidence of a disruption in iron homeostasis with plasma ferritin and nonheme iron concentrations being elevated among those with the ZZ genotype.

Keywords: α-1-antitrypsin deficiency, serpins, proteinase inhibitor proteins, ferritin, transferrin

Download Article [PDF] View Full Text [HTML] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Other article by this author:

Lung injury after cigarette smoking is particle related

Rahul G Sangani, Andrew J Ghio

International Journal of Chronic Obstructive Pulmonary Disease 2011, 6:191-198

Published Date: 10 March 2011

Readers of this article also read:

Cetuximab-conjugated iron oxide nanoparticles for cancer imaging and therapy

Tseng SH, Chou MY, Chu IM

International Journal of Nanomedicine 2015, 10:3663-3685

Published Date: 20 May 2015

Amalgamation of complex iron(III) ions and iron nanoclusters with MWCNTs as a route to potential T2 MRI contrast agents

Kuźnik N, Tomczyk MM, Wyskocka M, Przypis L, Herman AP, Jędrysiak R, Koziol KK, Boncel S

International Journal of Nanomedicine 2015, 10:3581-3591

Published Date: 14 May 2015

Functionalized magnetic iron oxide/alginate core-shell nanoparticles for targeting hyperthermia

Liao SH, Liu CH, Bastakoti BP, Suzuki N, Chang Y, Yamauchi Y, Lin FH, Wu KCW

International Journal of Nanomedicine 2015, 10:3315-3328

Published Date: 4 May 2015

Comparison of uncommon EGFR exon 21 L858R compound mutations with single mutation

Peng L, Song ZG, Jiao SC

OncoTargets and Therapy 2015, 8:905-910

Published Date: 21 April 2015

Non-chemotoxic induction of cancer cell death using magnetic nanowires

Contreras MF, Sougrat R, Zaher A, Ravasi T, Kosel J

International Journal of Nanomedicine 2015, 10:2141-2153

Published Date: 17 March 2015

New findings about iron oxide nanoparticles and their different effects on murine primary brain cells

Neubert J, Wagner S, Kiwit J, Bräuer AU, Glumm J

International Journal of Nanomedicine 2015, 10:2033-2049

Published Date: 13 March 2015

Fluorescent magnetic iron oxide nanoparticles for cardiac precursor cell selection from stromal vascular fraction and optimization for magnetic resonance imaging

Verma VK, Kamaraju SR, Kancherla R, Kona LK, Beevi SS, Debnath T, Usha SP, Vadapalli R, Arbab AS, Chelluri LK

International Journal of Nanomedicine 2015, 10:711-726

Published Date: 20 January 2015

Geroprotectors as a novel therapeutic strategy for COPD, an accelerating aging disease

Ito K, Colley T, Mercado N

International Journal of Chronic Obstructive Pulmonary Disease 2012, 7:641-652

Published Date: 21 September 2012

DataGenno: building a new tool to bridge molecular and clinical genetics

Fabricio F Costa, Luciano S Foly, Marcelo P Coutinho

The Application of Clinical Genetics 2011, 4:45-54

Published Date: 18 March 2011